A Personalized
Approach to Oncology
That Is Disrupting
Traditional Methods

Precision medicine is revolutionizing the attack on cancer-and our sole focus is to help you harness its power. We pursue cancer on a molecular level, using biomarkers to link specific mutations to specific treatments. We combine specialized oncology expertise and deep science with data from advanced technological platforms, to design and execute targeted, adaptive clinical trials. We work with your team to supply robust insights that inform real-time decisions and optimize the oncology development pathway.

Precision Site Network for predictable start-up and performance

In the 20+ years that we have been running oncology clinical trials and more, we’ve developed a network of 80+ global centers of excellence, the Precision Site Network (PSN) for oncology, immuno-oncology, CNS, cardiovascular studies and other complex indications. The PSN includes many of the world’s leading research organizations, and our ongoing relationship with these sites translates into rapid-study start-up (as little as 90 days for some sites), highly efficient operations, and dependable organizational quality.

Precision Site Network provides broad reach and specialized experience

90+ global centers of excellence

These are just a few of our PSN sites:

  • City of Hope
  • Mary Crowley
  • Moffitt
  • START (Grand Rapids)
  • START U.S. (San Antonio)
  • Sylvester Cancer Center
  • Penn State Univ @ Hershey
  • University of New Mexico
  • University of West Virginia
  • University of West Virginia SMO
  • Emory
  • CTRC (San Antonio)
  • University of Louisville
  • Roswell Park Cancer Institute
  • Frontier Cancer Center
  • Fox Chase
  • Institut du Cancer de Montpellier
  • Christie NHS
  • Sir Bobby Robson CRTC
  • Leeds (St. James) Cancer Centre
  • START – Madrid, Spain – 2 sites
  • Vall D’Hebron
  • Hospital Fuenlabrada
  • Erasmus MC

Precision’s Oncology Site Network: Find precisely the right sites for your complex oncology trial

Jump-starting immuno-oncology innovation

After a decade of progress, advances in immuno-oncology have slowed. Now, key scientific drivers and peer-reviewed research point to actionable ideas to reinvigorate innovation.

Customized oncology and immuno-oncology solutions

Discover how our oncology & immuno-oncology therapeutic area expertise can advance your clinical development program

Discover how our oncology & immuno-oncology therapeutic area expertise can advance your clinical development program

Services supporting oncology clinical development

Immune Monitoring

Leverage sophisticated immune monitoring approaches, including flow, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.


Find and monitor gene expression signatures, copy number variations, chromosome rearrangements, and other genomic events occurring in patient samples using NGS, NanoString, qPCR, ddPCR, and FISH/ISH.


Seasoned biostatisticians and statistical programmers deliver insight into every trial phase, from study design to regulatory submissions, all backed by meticulous documentation and data monitoring.

Explore other areas of expertise